KTRA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While KTRA seems to be doing ok healthwise, there are quite some concerns on its profitability. KTRA does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year KTRA has reported negative net income.
In the past year KTRA has reported a negative cash flow from operations.
In the past 5 years KTRA always reported negative net income.
In the past 5 years KTRA always reported negative operating cash flow.

1.2 Ratios

KTRA has a Return On Assets of -137.12%. This is amonst the worse of the industry: KTRA underperforms 84.01% of its industry peers.
The Return On Equity of KTRA (-226.35%) is worse than 70.69% of its industry peers.

		Industry Rank	Sector Rank
ROA	-137.12%
ROE	-226.35%
ROIC	N/A

ROA(3y)-224%

ROA(5y)-257.81%

ROE(3y)-832.26%

ROE(5y)-1280.11%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

KTRA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, KTRA has more shares outstanding
The number of shares outstanding for KTRA has been increased compared to 5 years ago.
KTRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -37.01, we must say that KTRA is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -37.01, KTRA is not doing good in the industry: 91.83% of the companies in the same industry are doing better.
KTRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-37.01

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 2.45 indicates that KTRA has no problem at all paying its short term obligations.
The Current ratio of KTRA (2.45) is worse than 72.11% of its industry peers.
A Quick Ratio of 2.45 indicates that KTRA has no problem at all paying its short term obligations.
KTRA has a Quick ratio of 2.45. This is in the lower half of the industry: KTRA underperforms 70.87% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.45
Quick Ratio	2.45

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.09% over the past year.

EPS 1Y (TTM)77.09%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%97.86%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, KTRA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.35% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y17.39%

EPS Next 2Y9.35%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KTRA. In the last year negative earnings were reported.
Also next year KTRA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.